About VentureCell
VentureCell is a cross-border investment network that connects investors in Singapore and across APAC with the best of UK/ European life science innovation.
VentureCell's venture portfolio is highly selective, with rigorous evaluation based on scientific excellence, leadership calibre, execution track record, commercial potential and scalability, and alignment/calibre of existing co-investors.
VentureCell operates as a brand of Kellbridge Capital Partners, the advisory arm that delivers bespoke capital raising and investor engagement partnerships.
Why join
Through a series of regular initiatives, members receive curated deal flow aligned to investor mandates and high-quality connections and strategic partnerships in health and life sciences.
Capital Intelligence &
Portfolio Brief
Our monthly, cross-border intelligence update on the most compelling trends in life sciences - including a spotlight on our top ventures shaping this theme.
LAUNCHING Q2 2026
Members' Events &
Venture Showcases
Members-only virtual and in-person events that bring together investors and founders around a focused topic, with curated venture showcases that forge high quality connections.
FIRST EVENT IN Q1 2026
Private Investors'
Circle
A private group of investors with privileged early visibility to the highest-conviction deals, priority cross-border syndicate access, and requests for targeted scouting.
LAUNCHING Q4 2026
Join the VentureCell Early Access List.
Join our growing investor waitlist, receive VentureCell's first issue of the
Intelligence & Portfolio Brief in April 2026 and exclusive event invitations.
Apply to VentureCell.
Are you an ambitious founder with a cutting edge life science venture seeking connections with Asia-based investors and partners? We want to hear from you.